Anthropometric and glucometabolic changes in an aged mouse model of lipocalin-2 overexpression

[1]  R. Cancedda,et al.  LCN2 overexpression in bone enhances the hematopoietic compartment via modulation of the bone marrow microenvironment , 2017, Journal of cellular physiology.

[2]  M. Rubin,et al.  MC4R-dependent suppression of appetite by bone-derived lipocalin 2 , 2017, Nature.

[3]  Paul E Kinahan,et al.  Brown Adipose Reporting Criteria in Imaging STudies (BARCIST 1.0): Recommendations for Standardized FDG-PET/CT Experiments in Humans. , 2016, Cell metabolism.

[4]  F. Nevens,et al.  Neutrophil gelatinase-associated lipocalin is a biomarker of acute-on-chronic liver failure and prognosis in cirrhosis. , 2016, Journal of hepatology.

[5]  P. Bruzzi,et al.  Divergent targets of glycolysis and oxidative phosphorylation result in additive effects of metformin and starvation in colon and breast cancer , 2016, Scientific Reports.

[6]  Sara Garbarino,et al.  A new compartmental method for the analysis of liver FDG kinetics in small animal models , 2015, EJNMMI Research.

[7]  S. Ravera,et al.  Fasting induces anti-Warburg effect that increases respiration but reduces ATP-synthesis to promote apoptosis in colon cancer models , 2015, Oncotarget.

[8]  R. Cancedda,et al.  Altered bone development and turnover in transgenic mice over‐expressing Lipocalin‐2 in bone , 2013, Journal of cellular physiology.

[9]  C. Campi,et al.  Direct inhibition of hexokinase activity by metformin at least partially impairs glucose metabolism and tumor growth in experimental breast cancer , 2013, Cell cycle.

[10]  Sushovan Guha,et al.  The multifaceted roles of neutrophil gelatinase associated lipocalin (NGAL) in inflammation and cancer. , 2012, Biochimica et biophysica acta.

[11]  J. H. Lee,et al.  Emerging clinical and experimental evidence for the role of lipocalin‐2 in metabolic syndrome , 2012, Clinical and experimental pharmacology & physiology.

[12]  C. Richart,et al.  Upregulation of Lipocalin 2 in Adipose Tissues of Severely Obese Women: Positive Relationship With Proinflammatory Cytokines , 2011, Obesity.

[13]  E. Rosen,et al.  A minor role for lipocalin 2 in high-fat diet-induced glucose intolerance. , 2011, American journal of physiology. Endocrinology and metabolism.

[14]  T. Clemens,et al.  The osteoblast: An insulin target cell controlling glucose homeostasis , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[15]  T. Mak,et al.  Lipocalin 2 is essential for chronic kidney disease progression in mice and humans. , 2010, The Journal of clinical investigation.

[16]  G. Shulman,et al.  Standard operating procedures for describing and performing metabolic tests of glucose homeostasis in mice , 2010, Disease Models & Mechanisms.

[17]  R. Cancedda,et al.  Lipocalin-2 controls the expression of SDF-1 and the number of responsive cells in bone. , 2010, Cytokine.

[18]  J. Kehrer.  Lipocalin-2: pro- or anti-apoptotic? , 2010, Cell Biology and Toxicology.

[19]  Wendy S. Wright,et al.  Lipocalin-2 Deficiency Impairs Thermogenesis and Potentiates Diet-Induced Insulin Resistance in Mice , 2010, Diabetes.

[20]  G Nolfe,et al.  Metabolic endotoxemia and saturated fat contribute to circulating NGAL concentrations in subjects with insulin resistance , 2010, International Journal of Obesity.

[21]  H. Randeva,et al.  Ex Vivo and In Vivo Regulation of Lipocalin-2, a Novel Adipokine, by Insulin , 2009, Diabetes Care.

[22]  Alan Aderem,et al.  Lipocalin 2 is required for BCR-ABL-induced tumorigenesis , 2008, Oncogene.

[23]  A. Xu,et al.  Adipose tissue and the metabolic syndrome: focusing on adiponectin and several novel adipokines. , 2008, Biomarkers in medicine.

[24]  Heike Münzberg,et al.  Mechanisms of leptin action and leptin resistance. , 2008, Annual review of physiology.

[25]  N. Houstis,et al.  The Adipokine Lipocalin 2 Is Regulated by Obesity and Promotes Insulin Resistance , 2007, Diabetes.

[26]  Laura Herrero,et al.  Obesity, inflammation, and insulin resistance. , 2007, Gastroenterology.

[27]  G. Hotamisligil,et al.  Inflammation and metabolic disorders , 2006, Nature.

[28]  A. Goldfine,et al.  Inflammation and insulin resistance. , 2006, The Journal of clinical investigation.

[29]  C. Mantzoros,et al.  Drug Insight: the role of leptin in human physiology and pathophysiology—emerging clinical applications , 2006, Nature Clinical Practice Endocrinology &Metabolism.

[30]  Shizuo Akira,et al.  Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron , 2004, Nature.

[31]  I. S. Wood,et al.  Adipokines: inflammation and the pleiotropic role of white adipose tissue , 2004, British Journal of Nutrition.

[32]  M. Desai,et al.  Obesity is associated with macrophage accumulation in adipose tissue. , 2003, The Journal of clinical investigation.

[33]  R. Cancedda,et al.  Extracellular fatty acid binding protein (Ex-FABP) modulation by inflammatory agents: "physiological" acute phase response in endochondral bone formation. , 2000, European journal of cell biology.

[34]  M. Lindstrom,et al.  Heterogeneous expression of the lipocalin NGAL in primary breast cancers , 1998, International journal of cancer.

[35]  M. Mizumoto,et al.  Identification of a neutrophil gelatinase-associated lipocalin mRNA in human pancreatic cancers using a modified signal sequence trap method. , 1998, Cancer letters.

[36]  Quansheng Liu,et al.  Uterocalin: A mouse acute phase protein expressed in the uterus around birth , 1997, Molecular reproduction and development.

[37]  D R Flower,et al.  The lipocalin protein family: structure and function. , 1996, The Biochemical journal.

[38]  Quansheng Liu,et al.  Identification of a New Acute Phase Protein (*) , 1995, The Journal of Biological Chemistry.

[39]  R. Devos,et al.  Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. , 1995, Science.

[40]  H. Tschesche,et al.  Cloning and expression of human neutrophil lipocalin cDNA derived from bone marrow and ovarian cancer cells , 1995, FEBS letters.

[41]  A. Van de Voorde,et al.  Identification by microsequencing of lipopolysaccharide-induced proteins secreted by mouse macrophages. , 1993, Journal of immunology.

[42]  G. Ailhaud,et al.  Regulation of adipose cell differentiation. I. Fatty acids are inducers of the aP2 gene expression. , 1991, Journal of lipid research.

[43]  C. Patlak,et al.  Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data. Generalizations , 1985, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[44]  A. Harden.  Obituary Notice: Adrian John Brown. , 1920, The Biochemical journal.

[45]  E. Kraegen,et al.  Lipocalin-2 is an inflammatory marker closely associated with obesity, insulin resistance, and hyperglycemia in humans. , 2007, Clinical chemistry.

[46]  G. Steinberg,et al.  Endurance training partially reverses dietary-induced leptin resistance in rodent skeletal muscle. , 2004, American journal of physiology. Endocrinology and metabolism.